IQVIA HOLDINGS INC. Proceeds from Lines of Credit
IQVIA HOLDINGS INC. (IQV) reported Proceeds from Lines of Credit of $550.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-05-05
- IQVIA HOLDINGS INC. proceeds from lines of credit for the quarter ending 2026-03-31 was $550.00M, a 100.00% increase year-over-year.
- IQVIA HOLDINGS INC. proceeds from lines of credit for the quarter ending 2025-12-31 was $2.00B, a 100.00% increase year-over-year.
- IQVIA HOLDINGS INC. proceeds from lines of credit for the quarter ending 2025-09-30 was $500.00M, a 61.29% increase year-over-year.
- IQVIA HOLDINGS INC. proceeds from lines of credit for the quarter ending 2025-06-30 was $600.00M, a 500.00% increase year-over-year.
- IQVIA HOLDINGS INC. proceeds from lines of credit for fiscal 2025 was $3.38B, a 100.30% increase from fiscal 2024.
- IQVIA HOLDINGS INC. proceeds from lines of credit for fiscal 2024 was $1.69B, a 29.32% decline from fiscal 2023.
- IQVIA HOLDINGS INC. proceeds from lines of credit for fiscal 2023 was $2.38B, a 1.45% increase from fiscal 2022.
- IQVIA HOLDINGS INC. proceeds from lines of credit for fiscal 2022 was $2.35B, a 190.12% increase from fiscal 2021.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-03-31 | $550.00M 10-Q · filed 2026-05-05 | $2.55B derived: sum of 2 quarters · filed 2026-05-05 | $3.05B derived: sum of 3 quarters · filed 2026-05-05 | $3.65B derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | $2.00B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.50B derived: sum of 2 quarters · filed 2026-02-17 | $3.10B derived: sum of 3 quarters · filed 2026-02-17 | $3.38B 10-K · filed 2026-02-17 |
| 2025-09-30 | $500.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.10B derived: sum of 2 quarters · filed 2025-10-28 | $1.38B 10-Q · filed 2025-10-28 | $2.38B derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-06-30 | $600.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $875.00M 10-Q · filed 2025-07-22 | $1.88B derived: sum of 3 quarters · filed 2026-05-05 | $2.19B derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-03-31 | $275.00M 10-Q · filed 2026-05-05 | $1.27B derived: sum of 2 quarters · filed 2026-05-05 | $1.58B derived: sum of 3 quarters · filed 2026-05-05 | $1.69B derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.00B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.31B derived: sum of 2 quarters · filed 2026-02-17 | $1.41B derived: sum of 3 quarters · filed 2026-02-17 | $1.69B 10-K · filed 2026-02-17 |
| 2024-09-30 | $310.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $410.00M derived: sum of 2 quarters · filed 2025-10-28 | $685.00M 10-Q · filed 2025-10-28 | $1.06B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $100.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $375.00M 10-Q · filed 2025-07-22 | $750.00M derived: sum of 3 quarters · filed 2026-02-17 | $1.20B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $275.00M 10-Q · filed 2025-05-06 | $650.00M derived: sum of 2 quarters · filed 2026-02-17 | $1.10B derived: sum of 3 quarters · filed 2026-02-17 | $2.18B derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $375.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $825.00M derived: sum of 2 quarters · filed 2026-02-17 | $1.91B derived: sum of 3 quarters · filed 2026-02-17 | $2.38B 10-K · filed 2026-02-17 |
| 2023-09-30 | $450.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $1.53B derived: sum of 2 quarters · filed 2024-10-31 | $2.01B 10-Q · filed 2024-10-31 | $2.86B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $1.08B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22 | $1.56B 10-Q · filed 2024-07-22 | $2.41B derived: sum of 3 quarters · filed 2025-02-13 | $2.76B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $475.00M 10-Q · filed 2024-05-02 | $1.32B derived: sum of 2 quarters · filed 2025-02-13 | $1.68B derived: sum of 3 quarters · filed 2025-02-13 | $1.88B derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $850.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $1.20B derived: sum of 2 quarters · filed 2025-02-13 | $1.40B derived: sum of 3 quarters · filed 2025-02-13 | $2.35B 10-K · filed 2025-02-13 |
| 2022-09-30 | $350.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $550.00M derived: sum of 2 quarters · filed 2023-11-01 | $1.50B 10-Q · filed 2023-11-01 | $1.90B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $200.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $1.15B 10-Q · filed 2023-08-01 | $1.55B derived: sum of 3 quarters · filed 2024-02-15 | $1.96B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $950.00M 10-Q · filed 2023-04-28 | $1.35B derived: sum of 2 quarters · filed 2024-02-15 | $1.76B derived: sum of 3 quarters · filed 2024-02-15 | $1.76B derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $400.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $810.00M derived: sum of 2 quarters · filed 2024-02-15 | $810.00M derived: sum of 3 quarters · filed 2024-02-15 | $810.00M 10-K · filed 2024-02-15 |
| 2021-09-30 | $410.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $410.00M derived: sum of 2 quarters · filed 2022-10-27 | $410.00M 10-Q · filed 2022-10-27 | $410.00M derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $0.00 10-Q · filed 2022-07-22 | $0.00 derived: sum of 3 quarters · filed 2023-02-15 | $0.00 derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-03-31 | $0.00 10-Q · filed 2022-04-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-15 | $0.00 derived: sum of 3 quarters · filed 2023-02-15 | $260.00M derived: sum of 4 quarters · filed 2023-02-15 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $0.00 derived: sum of 2 quarters · filed 2023-02-15 | $260.00M derived: sum of 3 quarters · filed 2023-02-15 | $1.25B 10-K · filed 2023-02-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | $260.00M derived: sum of 2 quarters · filed 2021-10-22 | $1.25B 10-Q · filed 2021-10-22 | $2.06B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $260.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $1.25B 10-Q · filed 2021-07-28 | $2.06B derived: sum of 3 quarters · filed 2022-02-16 | $2.67B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $990.00M 10-Q · filed 2021-04-23 | $1.80B derived: sum of 2 quarters · filed 2022-02-16 | $2.41B derived: sum of 3 quarters · filed 2022-02-16 | $2.72B derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $812.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $1.42B derived: sum of 2 quarters · filed 2022-02-16 | $1.73B derived: sum of 3 quarters · filed 2022-02-16 | $2.52B 10-K · filed 2022-02-16 |
| 2019-09-30 | $610.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | $920.00M derived: sum of 2 quarters · filed 2020-10-22 | $1.71B 10-Q · filed 2020-10-22 | $2.35B derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $310.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | $1.10B 10-Q · filed 2020-07-23 | $1.75B derived: sum of 3 quarters · filed 2021-02-12 | $2.08B derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $790.00M 10-Q · filed 2020-04-30 | $1.44B derived: sum of 2 quarters · filed 2021-02-12 | $1.77B derived: sum of 3 quarters · filed 2021-02-12 | $2.83B derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $645.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $985.00M derived: sum of 2 quarters · filed 2021-02-12 | $2.04B derived: sum of 3 quarters · filed 2021-02-12 | $2.44B 10-K · filed 2021-02-12 |
| 2018-09-30 | $340.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $1.40B derived: sum of 2 quarters · filed 2019-11-01 | $1.80B 10-Q · filed 2019-11-01 | $2.50B derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-06-30 | $1.05B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $1.46B 10-Q · filed 2019-07-24 | $2.16B derived: sum of 3 quarters · filed 2020-02-18 | $2.53B derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-03-31 | $405.00M 10-Q · filed 2019-05-02 | $1.10B derived: sum of 2 quarters · filed 2020-02-18 | $1.47B derived: sum of 3 quarters · filed 2020-02-18 | $1.84B derived: sum of 4 quarters · filed 2020-02-18 |
| 2017-12-31 | $699.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $1.07B derived: sum of 2 quarters · filed 2020-02-18 | $1.43B derived: sum of 3 quarters · filed 2020-02-18 | $1.92B 10-K · filed 2020-02-18 |
| 2017-09-30 | $369.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $732.00M derived: sum of 2 quarters · filed 2018-10-25 | $1.22B 10-Q · filed 2018-10-25 | |
| 2017-06-30 | $363.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $853.00M 10-Q · filed 2018-07-27 | ||
| 2017-03-31 | $490.00M 10-Q · filed 2018-05-04 | |||
| 2016-12-31 | $172.00M 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |